Assignee
PALVELLA THERAPEUTICS INC
US·7 granted patents·5 pending applications·9 citations·filing 2018–2025
Top patents by PatentIndex Score
12 records- 0191US11000513B2Anhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2019·Granted May 11, 2021·4 cites·22 claims
- 0290US11135204B2Anhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2020·Granted Oct 5, 2021·2 cites·11 claims
- 0388US12268673B2Anhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2021·Granted Apr 8, 2025·1 cites·11 claims
- 0487US11679101B2Anhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2021·Granted Jun 20, 2023·1 cites·52 claims
- 0583US2024398766A1ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEPALVELLA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0682US12329748B2Anhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2023·Granted Jun 17, 2025·0 cites·51 claims
- 0782US10722499B2Anyhydrous compositions of mTOR inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·1 cites·29 claims
- 0874US2025213537A1ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEPALVELLA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0969US11617742B2Methods of treating keratin hyperproliferation disorders using mTOR inhibitorsPALVELLA THERAPEUTICS INC·Filed 2020·Granted Apr 4, 2023·0 cites·10 claims
- 1061US2025228825A1Compositions of rapamycin and their use in the treatment of microcystic lymphatic malformationPALVELLA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1160US2023113775A1Anhydrous compositions of egfr inhibitors and methods of usePALVELLA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1259US2024293378A1Methods and compositions for treating gorlin syndromePALVELLA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →